Letters, Statements and Analysis

Communicating the importance of managed care pharmacy is a key part of AMCP’s work. Using AMCP policies as a basis for their work, AMCP staff and volunteers provide comments, analysis and testimony to Congress and other federal and state agencies on how proposed regulations and laws impact managed care pharmacy and the patients we serve.

 

2019

 

 2018

 

2017 

 

2016 

 

2015

 

May

5/18/2019

AMCP joins stakeholder group opposing FDA Update to Biosimilar Naming   

5/7/2019

AMCP Submitted Comments to the FDA on Updated Draft Guidance on Nonproprietary Naming of Biologics   

April

4/8/2019

AMCP submits comments to HHS OIG proposed rulemaking on Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees. 

4/3/2019

AMCP sends letter to Governor Hogan asking him to veto Maryland HB 435 which would impose unnecessary restrictions on formulary management 

March

3/1/2019

AMCP Submits Comments to CMS on Advance Notice of Methodological Changes for Calendar Year (CY) 2020 for Medicare Advantage (MA) Capitation Rates, Part C and Part D Payment Policies and 2020 Call Letter   

February

2/28/2019

AMCP Responds to A Request from Senator Alexander on Ways Congress and the Administration can Address the High Cost of Healthcare   

2/18/2019

AMCP Supports the Reintroduction of H.R. 965, the CREATES ACT   

2/18/2019

AMCP Submits Letter to Ways and Means Committee on Ways to Address Rising Drug Costs   

AMCP Supports the Reintroduction of S. 340, the CREATES ACT   

AMCP summary: Food and Drug Administration (FDA) Definition of the Term “Biological Product”   

2/12/2019

AMCP submits comments to the Office of Civil Rights (OCR) on its Request for Information on Modifying HIPAA Rules to Improve Coordinated Care   

2/06/2019

AMCP Summary: Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees   

2/05/2019

AMCP joins 50 other organizations in support of the reintroduction of the CREATES Act   

January

1/30/2019

AMCP Summary: Advance Notice of Methodological Changes for Calendar Year (CY) 2020 for Medicare Advantage (MA) Capitation Rates, Part C and Part D Payment Policies and 2020 Draft Call Letter   

1/28/2019

On January 28, AMCP submitted comments to HHS and ONC on the HHS Draft Strategy on Reducing Regulatory and Administrative Burden to the Use of Health IT and EHRs.   

1/25/2019

AMCP Submits Comments to CMS on Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses proposed rulemaking   

Content for class "break" Goes Here